Amydis

Amydis, Inc. is a private pharmaceutical company focused on developing innovative chemistry to detect diseases involving the presence of amyloids. Our mission is to develop a universal non-invasive diagnostic that is faster, more accessible, and more affordable than current disease tests where clinical and medical needs are unmet. Amydis has a new compound platform that fluoresces when bound to amyloids, enabling the diagnosis of these diseases.